$8.93
-0.34-3.67%
Pre-Market: 8:11 AM EDT
Comments
Loading...
Coeptis Therapeutics (NASDAQ:COEP) Stock, Earnings Estimates, EPS, And Revenue
Coeptis Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 25
EPS Estimate
$-0.800
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Coeptis Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Coeptis Therapeutics (COEP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-1.00 | $-1.00 | 0.00 % |
| Q4 | 2024-03-26 | $-1.60 | $-2.40 | 33.3 % |
| Q2 | 2023-08-11 | $-2.80 | $-4.00 | 30.0 % |
| Q1 | 2023-05-15 | $-7.80 | $-4.00 | -95.0 % |
Coeptis Therapeutics (COEP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Coeptis Therapeutics (NASDAQ:COEP) reporting earnings?
Coeptis Therapeutics (COEP) is scheduled to report earnings on March 25, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Coeptis Therapeutics (NASDAQ:COEP)?
The Actual EPS was $-1.00, which hit the estimate of $-1.00.
What were Coeptis Therapeutics’s (NASDAQ:COEP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.